BCLI BrainStorm Cell Therapeutics Inc.: Narxning prognoz qilingan daromadga nisbati
Brainstorm Cell (BCLI) hujayraviy mahsulotlarni ishlab chiqarishda tashqi cGMP inshootlaridan foydalanish orqali infratuzilma risklarini minimallashtiradi. Oldindan bashorat qilingan savdo daromadlariga nisbat koeffitsiyenti ushbu strategiyani tasdiqlaydi, bunda metriki maqsadli daraja sifatida xizmat qiladi. Biznesning rivojlanishi bozor sikllariga emas, balki ALS ni davolashdagi klinik muvaffaqiyatga bog'liq. Biomateriallarni utilizatsiya qilish paytidagi qat'iy sanitariya nazorati tadqiqotlarning ekologik xavfsizligini ta'minlaydi.
BrainStorm Cell Therapeutics Inc. (BCLI) boʻyicha maʼlumotlarning jamlanma tahliliy kesimlari
- bozor narxi va tahlilchilarning maqsadli narxlari:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning kapitalga nisbati Brainstorm Cell|BCLI - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Brainstorm Cell|BCLI - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans kapitallashuviga nisbati BrainStorm Cell Therapeutics Inc.|BCLI - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzi BrainStorm Cell Therapeutics|Tezkor likvidlik koeffitsiyenti brainstorm-cell.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
BCLI - Kompaniyaning sof foydasi|Prognoz qilingan kelajakdagi foyda Brainstorm Cell|BCLI - Narx-foyda koeffitsiyenti|Kelajakdagi narxning foydaga nisbati Brainstorm Cell Therapeutics, Inc.|BCLI - Narxning foydaga va o‘sish sur’atiga nisbati|EV/EBITDA multiplikatori BrainStorm Cell Therapeutics Inc.|BCLI - Amortizatsiya chegirilmasdan oldingi operatsion daromad|So'nggi o'n ikki oy davomida bir aksiya uchun foyda BrainStorm Cell Therapeutics|BCLI - So'nggi 12 oy davomida bir aksiya uchun foyda|Choraklik EPS foyda o'sishi brainstorm-cell.com|BCLI - Joriy yilda bir aksiya uchun foydaning o'sish sur'ati|Keyingi yil uchun bir aksiya uchun kutilayotgan foyda o'sishi Brainstorm Cell
- sotuvlar va tushum bo'yicha ma'lumotlar:
Kompaniyaning dastlabki tahlili:BCLI (BrainStorm Cell Therapeutics)
Brainstorm Cell (BCLI) kompaniyasining o'ziga xos xususiyatlari va FDA tasdig'iga bo'lgan uzoq muddatli kutishlari oldingi sotuvlar nisbatini (forward price-to-sales ratio) biznesning xarajatlar inflyatsiyasiga chidamliligini baholash uchun asosiy vositaga aylantiradi. Ushbu grafik kelajakdagi sotuvlarga bo'lgan bozor kutishlarini aks ettirib, investorlarga choraklik hisobotlarni kutmasdan kapital zaifliklarini va R&D xarajatlarining aktivlar qiymatiga ta'sirini zudlik bilan aniqlash imkonini beradi.
Brainstorm Cell kimlar bilan raqobatlashadi
Narxning prognoz qilingan daromadga nisbati Biogen BIIB|Neurocrine (NBIX) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|RGC - Narxning prognoz qilingan daromadga nisbati|Sotuvga nisbatan forvard narx AXSM (Axsome Corp)|ACADIA Pharmaceuticals (ACAD) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori xenon-pharma.com|Forvard narx/daromad multiplikatori VKTX|SUPN: Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori CPRX|Forvard narx/daromad multiplikatori Denali Corp DNLI|Forvard P/S multiplikatori HRMY (Harmony Biosciences)|biohavenpharma.com (BHVN) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|AMLX - Narxning prognoz qilingan daromadga nisbati|TRVI: Narxning prognoz qilingan daromadga nisbati|Praxis Medicines (PRAX) - Narxning prognoz qilingan daromadga nisbati|AVXL (Anavex Life Sciences Corp) - Narxning prognoz qilingan daromadga nisbati|CBLL (CeriBell, Inc.) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati PRTA|Forvard P/S multiplikatori ALEC|Forvard narx/daromad multiplikatori Annexon Biosciences ANNX|Narxning prognoz qilingan daromadga nisbati Omeros OMER|Neurogene Therapeutics - Narxning prognoz qilingan daromadga nisbati|AC Immune - Forvard P/S multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati voyagertherapeutics.com VYGR|Neumora Therapeutics, Inc. (NMRA) - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning prognoz qilingan daromadga nisbati SCLX|TVGN (Tevogen Bio Holdings, Inc.) - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Alpha Cognition Corp ACOG|Forvard narx/daromad multiplikatori CGTX (Cognition Therapeutics)|Forvard P/S multiplikatori inhibikase.com (IKT)|Narxning prognoz qilingan daromadga nisbati Cassava Sciences SAVA|Sotuvga nisbatan forvard narx ASRT|COYA - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati Vistagen Therapeutics|OVID: Forvard P/S multiplikatori|ABOS (acumenpharm.com) - Narxning prognoz qilingan daromadga nisbati|Narxning prognoz qilingan daromadga nisbati CervoMed|ATHE: Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori CLNN|Forvard P/S multiplikatori pepgen.com (PEPG)|Forvard P/S multiplikatori JUNS (Jupiter Neurosciences Inc)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati relmada.com (RLMD)|ANVS - Narxning prognoz qilingan daromadga nisbati|GRCE (Grace Therapeutics, Inc.) - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Firefly Neuroscience Inc (AIFF) - Narxning prognoz qilingan daromadga nisbati|KLTO - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard narx/daromad multiplikatori NRSN|RVPH (revivapharma.com) - Narxning kutilayotgan daromadga nisbati|Narxning prognoz qilingan daromadga nisbati MetaVia Inc (MTVA)|NRXS - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Helius Medical Technologies HSDT|Sotuvga nisbatan forvard narx PASG|NEUP - Narxning prognoz qilingan daromadga nisbati|minervaneurosciences.com (NERV) - Forvard narx/daromad multiplikatori|ATHA (Athira Pharma) - Forvard narx/daromad multiplikatori|Addex Therapeutics Ltd. - Sotuvga nisbatan forvard narx|ALZN (Alzamend Neuro Inc.) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Cyclerion (CYCN)|Forvard P/S multiplikatori PTIX|KTTA - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Cortigent CRGT|Avenue Therapeutics Inc. - Narxning prognoz qilingan daromadga nisbati|CARA - Narxning prognoz qilingan daromadga nisbati|CHRO: Narxning prognoz qilingan daromadga nisbati|ELYM: Forvard P/S multiplikatori|ITCI (Intra-Cellular Therapies, Inc.) - Narxning prognoz qilingan daromadga nisbati|LBPH (Longboard Pharmaceuticals, Inc.) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Marinus Pharmaceuticals Inc (MRNS)|Narxning prognoz qilingan daromadga nisbati NKGen (NKGN)|Narxning prognoz qilingan daromadga nisbati NRBO (NeuroBo Pharma)|Forvard P/S multiplikatori SAGE (Sage Therapeutics, Inc.)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati synaptogen.com (SNPX)|TRVN - Narxning prognoz qilingan daromadga nisbati|VIGL (Vigil Neuroscience) - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|WENA: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Cerevel Corp (CERE)
